Heart sphingolipids in health and disease.

Heart sphingolipids in health and disease.

Item
http://www.wikidata.org/entity/Q37930545
Lactosylceramide contributes to mitochondrial dysfunction in diabetesErythrocyte very long-chain saturated fatty acids associated with lower risk of incident sudden cardiac arrestMechanisms of heart failure in obesity.Cholesteryl esters accumulate in the heart in a porcine model of ischemia and reperfusionMyristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.Sphingolipids and mitochondrial apoptosis.Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.Ceramide signaling in the coronary microcirculation: a double-edged sword?Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.
P2860

Heart sphingolipids in health and disease.

Item
http://www.wikidata.org/entity/Q37930545
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heart sphingolipids in health and disease.
@en
Heart sphingolipids in health and disease.
@nl
type
label
Heart sphingolipids in health and disease.
@en
Heart sphingolipids in health and disease.
@nl
prefLabel
Heart sphingolipids in health and disease.
@en
Heart sphingolipids in health and disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P698
P356
P1433
P1476
Heart sphingolipids in health and disease
@en
P2093
P304
P31
P356
10.1007/978-1-4614-0650-1_3
P407
P478
P50
P577
P698